XML 81 R93.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Condensed Consolidating Guarantor and Non-Guarantor Financial Information - Condensed Consolidating Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended 3 Months Ended 7 Months Ended 12 Months Ended 7 Months Ended 12 Months Ended 7 Months Ended 12 Months Ended 7 Months Ended 12 Months Ended 7 Months Ended 12 Months Ended 5 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Dec. 31, 2012
Mar. 31, 2013
Guarantors The Hillman Companies, Inc.
Mar. 31, 2013
Issuer The Hillman Group, Inc.
Mar. 31, 2012
Issuer The Hillman Group, Inc.
Mar. 31, 2013
Guarantor Subsidiaries
Mar. 31, 2012
Guarantor Subsidiaries
Mar. 31, 2013
Non-Guarantor Subsidiaries
Mar. 31, 2012
Non-Guarantor Subsidiaries
Dec. 31, 2010
Successor
Dec. 31, 2012
Successor
Dec. 31, 2011
Successor
Dec. 31, 2010
Successor
Guarantors The Hillman Companies, Inc.
Dec. 31, 2012
Successor
Guarantors The Hillman Companies, Inc.
Dec. 31, 2011
Successor
Guarantors The Hillman Companies, Inc.
Dec. 31, 2010
Successor
Issuer The Hillman Group, Inc.
Dec. 31, 2012
Successor
Issuer The Hillman Group, Inc.
Dec. 31, 2011
Successor
Issuer The Hillman Group, Inc.
Dec. 31, 2010
Successor
Guarantor Subsidiaries
Dec. 31, 2012
Successor
Guarantor Subsidiaries
Dec. 31, 2011
Successor
Guarantor Subsidiaries
Dec. 31, 2010
Successor
Non-Guarantor Subsidiaries
Dec. 31, 2012
Successor
Non-Guarantor Subsidiaries
Dec. 31, 2011
Successor
Non-Guarantor Subsidiaries
Dec. 31, 2012
Successor
Consolidating Adjustments
Dec. 31, 2011
Successor
Consolidating Adjustments
May 28, 2010
Predecessor
May 28, 2010
Predecessor
Guarantors The Hillman Companies, Inc.
May 28, 2010
Predecessor
Issuer The Hillman Group, Inc.
May 28, 2010
Predecessor
Guarantor Subsidiaries
May 28, 2010
Predecessor
Non-Guarantor Subsidiaries
Cash flows from operating activities:                                                                
Net income (loss) $ (4,585) $ (2,587)   $ (1,788) $ (2,513) $ (486) $ 317 $ 54 $ (548) $ (12) $ (8,038) $ (7,234) $ (9,779) $ (7,013) $ (12,008) $ (12,456) $ (1,401) $ 6,809 $ 1,763 $ 224 $ 548 $ 1,061 $ 211 $ (2,571) $ (225) $ (12) $ 78 $ (25,208) $ (24,810) $ (493) $ (143) $ 227
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:                                                                
Depreciation and amortization 10,988 11,360   4,515 6,120 6,701 15 22 338 122 21,676 43,761 42,050 10,669 18,058 18,433 10,924 25,137 23,216 50 88 328 33 478 73     9,961 2,663 7,192 47 59
Dispositions of property and equipment 9        9                60 292 53       60 271 42   21 11           74   74    
Deferred income tax provision (benefit) (3,033) (1,815)   (3,122)    446 (809) 37 898 137 (5,660) (5,603) (4,634) (8,031) (6,382) (8,866) (1,125) 1,686 (203) 176 300 1,350 3,320 (1,207) 3,085     (1,921) (2,757) 733 45 58
Deferred financing and original issue discount amortization 583 498   (46) 629 605             1,294 2,180 2,011 2,590 (279) (803) (1,296) 2,459 2,814                 515 (155) 670    
Interest on mandatorily redeemable preferred stock and management purchased options                                                       5,488 5,488      
Stock-based compensation expense 261   714 261                  714     714                         19,053 19,053      
Other non-cash interest and change in value of interest rate swap (207) (163)      (207) (163)           392 (787) 1,250       392 (787) 1,250                          
Changes in operating items:                                                                
Accounts receivable (13,176) (8,637)      (7,269) (7,745) (2,842) (241) (3,065) (651) 14,686 1,376 (4,441)       14,195 2,431 (6,673) 727 (50) 2,162 (236) (1,005) 70     (16,816)   (15,724) (658) (434)
Inventories (1,959) (2,330)      (3,954) (2,811) (3,357) 679 5,299 (211) (11,661) (10,380) (2,175)       (11,030) (9,788) (7,647) (100) 439 5,527 (590) (1,043) 23 12 (78) 2,959   2,383 477 110
Other assets 2,207 (563)      (10,295) 9 9,590 (400) 2,912 (172) (1,156) (3,931) (3,251)       (2,626) (6,003) (4,691) 38 (1,319) 92 1,444 3,391 1,348     124   597 (178) (307)
Accounts payable 2,739 2,582      (344) 2,684 628 (5) 2,455 (97) 7,051 (1,146) 672       7,229 (568) 387 (374) (138) (4) 196 (440) 289     1,830   1,890 (71) 11
Interest payable on junior subordinated debentures 1,019     1,019                                                           
Other accrued liabilities (2,263) 2,237   176 2,264 5,019 94 (29) (930) 152 (5,780) 5,146 2,291 (69) (76) (265) (11,228) 3,623 4,053 4 121 (1,708) 417 1,478 211     4,352 (332) 9,561 176 43
Other items, net 821 (294)   (1,015) (8,110) (3,229) (2,316)    8,395 (127) (1,665) (970) 166 199,620 (27) 3,957 (214,228) (1,645) 8,989 21,567 (3) (9,361) (3,540) 705 (3,419)     (894) 850 (6,843)   15
Net cash provided by (used for) operating activities (6,596) 288      (23,670) 1,030 1,320 117 15,754 (859) 11,199 23,418 24,213 197,766     (210,134) 23,625 23,300 22,312 7 (542) 1,255 (214) 1,455     (483)   40 (305) (218)
Cash flows from investing activities:                                                                
Paulin acquisition (103,416)        (103,416)                 (40,271)           (40,271)                          
Payments for Quick Tag and Laser Key licenses                     (12,750)           (12,750)                              
Proceeds from sale of property and equipment   3            3        3                 3                      
Payment for Ook acquisition                         (15,323)           (15,323)                          
Payment for Servalite acquisition                     (21,335)                 (21,335)                        
Capital expenditures (6,651) (5,447)      (6,590) (5,371) (9) (6) (52) (70) (9,675) (24,313) (17,935)       (9,518) (23,973) (17,778) (64) (128) (30) (93) (212) (127)     (5,411)   (5,396) (7) (8)
Other, net                                                                                
Net cash used for investing activities (110,067) (5,444)      (110,006) (5,371) (9) (3) (52) (70) (43,760) (24,310) (73,529)       (22,268) (23,973) (73,372) (21,399) (125) (30) (93) (212) (127)     (5,411)   (5,396) (7) (8)
Cash flows from financing activities:                                                                
Borrowings of senior term loans 76,800        76,800             290,000   30,000       290,000   30,000                          
Repayments of senior term loans (800) (800)      (800) (800)             (149,756) (3,200) (2,975)       (149,756) (3,200) (2,975)                 (9,544)   (9,544)    
Discount on senior term loans (2,152)        (2,152)                 (2,000)           (2,000)                          
Borrowings of revolving credit loans   14,000       14,000           12,600 19,000 9,444       12,600 19,000 9,444                          
Repayments of revolving credit loans                     (600) (19,000) (21,444)       (600) (19,000) (21,444)                          
Payment of additional acquisition consideration   (12,387)       (12,387)             (12,387) (12,490)         (12,387) (12,490)                          
Principal payments under capitalized lease obligations (94) (7)      (94) (7)             (50) (47) (30)       (50) (47) (30)                 (459)   (459)    
Repayments of unsecured subordinated notes                     (49,820)           (49,820)                              
Borrowings under other credit obligations                       1,119           1,119                            
Repayments of other credit obligations                       (297)           (297)                            
Borrowings of senior notes                         150,000 65,000 50,000       150,000 65,000 50,000                          
Premium on senior notes                           4,225 4,625         4,225 4,625                          
Financing fees, net                         (15,729)   (1,372)       (15,729)   (1,372)                          
Purchase predecessor equity securities                     (506,407)     (506,407)                                    
Proceeds from sale of successor equity securities                     308,641     308,641                                    
Net cash (used for) provided by financing activities 73,754 806      73,754 806             38,879 54,413 53,758 (197,766)     236,645 54,413 53,758                 (10,003)   (10,003)    
Net (decrease) increase in cash and cash equivalents (42,909) (4,350)      (59,922) (3,535) 1,311 114 15,702 (929) 6,318 53,521 4,442       4,243 54,065 3,686 913 (118) (572) 1,162 (426) 1,328     (15,897)   (15,359) (312) (226)
Cash and cash equivalents at beginning of period 65,548 12,027 12,027 1 62,917 8,852 429 547 2,201 2,627 1,267 12,027 7,585 1 1 1 923 8,852 5,166 206 547 1,119 137 2,627 1,299     17,164 1 16,282 518 363
Cash and cash equivalents at end of period $ 22,639 $ 7,677 $ 65,548 $ 1 $ 2,995 $ 5,317 $ 1,740 $ 661 $ 17,903 $ 1,698 $ 7,585 $ 65,548 $ 12,027 $ 1 $ 1 $ 1 $ 5,166 $ 62,917 $ 8,852 $ 1,119 $ 429 $ 547 $ 1,299 $ 2,201 $ 2,627     $ 1,267 $ 1 $ 923 $ 206 $ 137